/EBAC

EBAC Stock - European Biotech Acquisition Corp.

Q: What is the analyst price target for EBAC?

Analyst price target information is not currently available for EBAC.

Q: What is EBAC's market cap?

Market capitalization information is not currently available for EBAC.

Financial Services|Shell Companies|NASDAQ

$11.19-4.44%

$0.52 (-4.44%) • Mar 2

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $12.31

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for EBAC

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.00

52W High$14.10

52W Low$9.28

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2022	FY2021
Revenue	N/A	N/A
Gross Profit	N/A	N/A
Gross Margin	N/A	N/A
Operating Income	$-2,818,000	$-1,100,000
Net Income	$3.50M	$1.48M
Net Margin	N/A	N/A
EPS	$0.27	$0.43

Company Overview

European Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. European Biotech Acquisition Corp. was incorporated in 2021 and is based in Amsterdam, the Netherlands.

Visit Website

Frequently Asked Questions about EBAC

What is EBAC's current stock price?

European Biotech Acquisition Corp. (EBAC) is currently trading at $11.19 per share. The stock has moved -4.44% today.

What is the analyst price target for EBAC?

No analyst price targets are currently available for this stock.

What sector is European Biotech Acquisition Corp. in?

European Biotech Acquisition Corp. operates in the Financial Services sector, specifically within the Shell Companies industry. The company is traded on the NASDAQ exchange.

What is EBAC's market cap?

European Biotech Acquisition Corp. has a market capitalization of $0.18 billion, making it a small-cap company.

Does EBAC pay dividends?

No, European Biotech Acquisition Corp. does not currently pay a dividend to shareholders.